Literature DB >> 19373515

Small RNA: a large contributor to carcinogenesis?

Imran Bhatti1, Andrew Lee, Jonathan Lund, Michael Larvin.   

Abstract

INTRODUCTION: Homeostasis in normal tissue includes balancing cell proliferation and apoptosis (programmed cell death). Mutations in proto-oncogenes or tumor suppressor genes may lead to disruption of normal cellular function, uncontrolled cell proliferation, and subsequent carcinogenesis. DISCUSSION: Micro-RNAs (miRNAs) are short (19-24 nucleotide) noncoding RNA sequences that inhibit protein translation and can cause the degradation of subsequent messenger RNA, thus playing an important role in the regulation of gene expression. Aberrant expression of miRNAs has been shown to inhibit tumor suppressor genes or inappropriately activate oncogenes initiating the cancer process. Unique miRNA expression profiles have been found in different cancer types at different stages, suggesting a possible diagnostic application. This review summarizes the current evidence supporting a link between aberrant miRNA expression and carcinogenesis and its possible role in improving diagnosis and treatment of cancers, particularly of gastrointestinal origin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373515     DOI: 10.1007/s11605-009-0887-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  82 in total

1.  Noise amidst the silence: off-target effects of siRNAs?

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Trends Genet       Date:  2004-11       Impact factor: 11.639

Review 2.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

3.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

4.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  Role of microRNAs in drug-resistant ovarian cancer cells.

Authors:  Antonio Sorrentino; Chang-Gong Liu; Antonio Addario; Cesare Peschle; Giovanni Scambia; Cristiano Ferlini
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

8.  Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.

Authors:  Kazuo Motoyama; Hiroshi Inoue; Yoshito Nakamura; Hiroyuki Uetake; Kenichi Sugihara; Masaki Mori
Journal:  Clin Cancer Res       Date:  2008-04-15       Impact factor: 12.531

Review 9.  Analysis of the E-cadherin repressor Snail in primary human cancers.

Authors:  K-F Becker; E Rosivatz; K Blechschmidt; E Kremmer; M Sarbia; H Höfler
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

10.  Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.

Authors:  Michael D Mattie; Christopher C Benz; Jessica Bowers; Kelly Sensinger; Linda Wong; Gary K Scott; Vita Fedele; David Ginzinger; Robert Getts; Chris Haqq
Journal:  Mol Cancer       Date:  2006-06-19       Impact factor: 27.401

View more
  12 in total

1.  Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma.

Authors:  Angela J Yoon; Shuang Wang; Jing Shen; Nicolas Robine; Elizabeth Philipone; Martin W Oster; Albert Nam; Regina M Santella
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 2.  MicroRNAs in pancreatic malignancy: progress and promises.

Authors:  Sanjeev K Srivastava; Sumit Arora; Seema Singh; Arun Bhardwaj; Courey Averett; Ajay P Singh
Journal:  Cancer Lett       Date:  2014-02-20       Impact factor: 8.679

Review 3.  Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

Authors:  Norihisa Uemura; Tadashi Kondo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.

Authors:  Imran Bhatti; Andrew Lee; Victoria James; Richard I Hall; Jonathan N Lund; Cristina Tufarelli; Dileep N Lobo; Michael Larvin
Journal:  J Gastrointest Surg       Date:  2010-11-19       Impact factor: 3.452

Review 5.  The next thing in prognostic molecular markers: microRNA signatures of cancer.

Authors:  William M Grady; Muneesh Tewari
Journal:  Gut       Date:  2010-06       Impact factor: 23.059

6.  MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.

Authors:  Xinqi He; Yujuan Dong; Chung Wah Wu; Zengren Zhao; Simon S M Ng; Francis K L Chan; Joseph J Y Sung; Jun Yu
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

Review 7.  Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.

Authors:  Ingrid Garajová; Tessa Y Le Large; Adam E Frampton; Christian Rolfo; Johannes Voortman; Elisa Giovannetti
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

Review 8.  Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review.

Authors:  Chang-Juan Tao; Gang Lin; Ya-Ping Xu; Wei-Min Mao
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

9.  MiR-221 Expression Level Correlates with Insulin-Induced Doxorubicin Resistance in MCF-7 Breast Cancer Cells.

Authors:  Parisa Kheradmand; Sadeq Vallian Boroojeni; Saeed Esmaeili-Mahani
Journal:  Cell J       Date:  2021-07-17       Impact factor: 2.479

10.  MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders.

Authors:  Yao Yuan; Siddha Kasar; Chingiz Underbayev; Sindhuri Prakash; Elizabeth Raveche
Journal:  Leuk Res Treatment       Date:  2012-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.